SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions

Oncogene

Volumn 22, Issue 32, 2003, Pages 5021-5030

  Sato, Norihiro ^a   Fukushima, Noriyoshi ^a   Maehara, Naoki ^a   Matsubayashi, Hiroyuki ^a   Koopmann, Jens ^a   Su, Gloria H ^a   Hruban, Ralph H ^a   Goggins, Michael ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Methylation; Pancreatic cancer; SPARC; Tumor stromal interaction

Indexed keywords

DNA; MESSENGER RNA; OSTEONECTIN;

ADULT; AGED; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA; ADENOCARCINOMA; ANIMAL; CANCER INVASION; CELL COMMUNICATION; GENETICS; METABOLISM; PANCREAS TUMOR; PATHOLOGY; STROMA CELL;

ADENOCARCINOMA; ANIMALS; CELL COMMUNICATION; DNA METHYLATION; MALE; NEOPLASM INVASIVENESS; OSTEONECTIN; PANCREATIC NEOPLASMS; STROMAL CELLS;

EID: 0042284883     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206807     Document Type: Article

References (51)

1. Bellahcene A and Castronovo V. (1995). Am. J. Pathol., 146, 95-100.
2. Bradshaw AD, Francki A, Motamed K, Howe C and Sage EH. (1999). Mol. Biol. Cell, 10, 1569-1579.
3. Bradshaw AD and Sage EH. (2001). J. Clin. Invest., 107, 1049-1054.
4. Brekken RA, Puolakkainen P, Graves DC, Workman G, Lubkin SR and Sage EH. (2003). J. Clin. Invest., 111, 482, 487-495.
5. Brekken RA and Sage EH. (2001). Matrix Biol., 19, 816-827.
6. Briggs J, Chamboredon S, Castellazzi M, Kerry JA and Bos TJ. (2002). Oncogene, 21, 7077-7091.
7. Dhanesuan N, Sharp JA, Blick T, Price JT and Thompson EW. (2002). Breast Cancer Res. Treat., 75, 73-85.
8. Francki A, Bradshaw AD, Bassuk JA, Howe CC, Couser WG and Sage EH. (1999). J. Biol. Chem., 274, 32145-32152.
9. Francki A, Motamed K, McClure TD, Kaya M, Murri C, Blake DJ, Carbon JG and Sage EH. (2003). J. Cell. Biochem., 88, 802-811.
10. Fukushima N, Sato N, Ueki T, Rosty C, Walter KM, Wilentz RE, Yeo CJ, Hruban RH and Goggins M. (2002). Am. J. Pathol., 160, 1573-1581.
11. Fukushima N, Walter KM, Ueki T, Sato N, Matsubayashi H, Cameron JL, Hruban RH, Canto M, Yeo CJ and Goggins M. (2003). Cancer Biol. Ther., 2, 78-83.
12. Funk SE and Sage EH. (1991). Proc. Natl. Acad. Sci. USA, 88, 2648-2652.
13. Funk SE and Sage EH. (1993). J. Cell Physiol., 154, 53-63.
14. Goggins M, Canto M and Hruban R. (2000). J. Surg. Oncol., 74, 243-248.
15. Hahn SA, Seymour AB, Hoque AT, Schutte M, da Costa LT, Redston MS, Caldas C, Weinstein CL, Fischer A, Yeo CJ, Hruban RH and Kern SE. (1995). Cancer Res., 55, 4670-4675.
16. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB. (1996). Proc. Natl. Acad. Sci. USA, 93, 9821-9826.
17. Iacobuzio-Donahue CA, Argani P, Hempen PM, Jones J and Kern SE. (2002a). Cancer Res., 62, 5351-5357.
18. Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, Van Heek NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq R, Jaffee E, Ryu B, Jones J, Eshleman JR, Yeo CJ, Cameron JL, Kern SE, Hruban RH, Brown PO and Goggins M. (2003). Am. J. Pathol., 162, 1151-1162.
19. Iacobuzio-Donahue CA, Ryu B, Hruban RH and Kern SE. (2002b). Am. J. Pathol., 160, 91-99.
20. Jacob K, Webber M, Benayahu D and Kleinman HK. (1999). Cancer Res., 59, 4453-4457.
21. Jansen M, Fukushima N, Rosty C, Walter K, Altink R, Heek TV, Hruban R, Offerhaus JG and Goggins M. (2002). Cancer Biol. Ther., 1, 293-296.
22. Jendraschak E and Sage EH. (1996). Semin. Cancer Biol., 7, 139-146.
23. Jones PA and Baylin SB. (2002). Nat. Rev. Genet., 3, 415-428.
24. Kern SE. (2000). Med. Clin. North Am., 84, 691-695.
25. Le Bail B, Faouzi S, Boussarie L, Guirouilh J, Blanc JF, Carles J, Bioulac-Sage P, Balabaud C and Rosenbaum J. (1999). J. Pathol., 189, 46-52.
26. Ledda F, Bravo AI, Adris S, Bover L, Mordoh J and Podhajcer OL. (1997). J. Invest. Dermatol., 108, 210-214.
27. Maehara N, Matsumoto K, Kuba K, Mizumoto K, Tanaka M and Nakamura T. (2001). Br. J. Cancer, 84, 864-873.
28. Massi D, Franchi A, Borgognoni L, Reali UM and Santucci M. (1999). Hum. Pathol., 30, 339-344.
29. Matsubayashi H, Sato N, Fukushima N, Yeo CJ, Walter KM, Brune K, Sahin F, Cameron JL, Hruban RH and Goggins M. (2003). Clin. Cancer Res., 9, 1446-1452.
30. Mok SC, Chan WY, Wong KK, Muto MG and Berkowitz RS. (1996). Oncogene, 12, 1895-1901.
31. Paley PJ, Goff BA, Gown AM, Greer BE and Sage EH. (2000). Gynecol. Oncol., 78, 336-341.
32. Porte H, Chastre E, Prevot S, Nordlinger B, Empereur S, Basset P, Chambon P and Gespach C. (1995). Int. J. Cancer, 64, 70-75.
33. Porte H, Triboulet JP, Kotelevets L, Carrat F, Prevot S, Nordlinger B, DiGioia Y, Wurtz A, Comoglio P, Gespach C and Chastre E. (1998). Clin. Cancer Res., 4, 1375-1382.
34. Porter PL, Sage EH, Lane TF, Funk SE and Gown AM. (1995). J. Histochem. Cytochem., 43, 791-800.
35. Rempel SA, Ge S and Gutierrez JA. (1999). Clin. Cancer Res., 5, 237-241.
36. Rosty C, Christa L, Kuzdzal S, Baldwin WM, Zahurak ML, Carnot F, Chan DW, Canto M, Lillemoe KD, Cameron JL, Yeo CJ, Hruban RH and Goggins M. (2002a). Cancer Res., 62, 1868-1875.
37. Rosty C and Goggins M. (2002). Hematol. Oncol. Clin. North Am., 16, 37-52.
38. Rosty C, Ueki T, Argani P, Jansen M, Yeo CJ, Cameron JL, Hruban RH and Goggins M. (2002b). Am. J. Pathol., 160, 45-50.
39. Ryu B, Jones J, Hollingsworth MA, Hruban RH and Kern SE. (2001). Cancer Res., 61, 1833-1838.
40. Sato N, Fukushima N, Maitra A, Matsubayashi H, Yeo CJ, Cameron JL, Hruban RH and Goggins M. (2003a). Cancer Res., in press.
41. Sato N, Maehara N, Su GH and Goggins M. (2003b). J. Natl. Cancer Inst., 95, 327-330.
42. Sato N, Ueki T, Fukushima N, Iacobuzio-Donahue CA, Yeo CJ, Cameron JL, Hruban RH and Goggins M. (2002). Gastroenterology, 123, 365-372.
43. Schultz C, Lemke N, Ge S, Golembieski WA and Rempel SA. (2002). Cancer Res., 62, 6270-6277.
44. Thomas R, True LD, Bassuk JA, Lange PH and Vessella RL. (2000). Clin. Cancer Res., 6, 1140-1149.
45. Ueki T, Toyota M, Skinner H, Walter KM, Yeo CJ, Issa JP, Hruban RH and Goggins M. (2001). Cancer Res., 61, 8540-8546.
46. Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, Hruban RH and Goggins M. (2000). Cancer Res., 60, 1835-1839.
47. Ueki T, Walter KM, Skinner H, Jaffee E, Hruban RH and Goggins M. (2002). Oncoqene, 21, 2114-2117.
48. Wewer UM, Albrechtsen R, Fisher LW, Young MF and Termine JD. (1988). Am. J. Pathol., 132, 345-355.
49. Yamanaka M, Kanda K, Li NC, Fukumori T, Oka N, Kanayama HO and Kagawa S. (2001). J. Urol., 166, 2495-2499.
50. Yan Q and Sage EH. (1999). J. Histochem. Cytochem., 47, 1495-1506.
51. Yiu GK, Chan WY, Ng SW, Chan PS, Cheung KK, Berkowitz RS and Mok SC. (2001). Am. J. Pathol., 159, 609-622.